| OPKO HEALTH INC. DL-,01 |
| USA |
| Gesundheit |
| US68375N1037 / A0MUUJ |
| XCY (Frankfurt) / OPK (NASDAQ) |
| FRA:XCY, ETR:XCY, XCY:GR, NASDAQ:OPK |
| - |
| https://www.opko.com/ |
|
OPKO Health, Inc. is a diversified healthcare company focused on diagnostics and pharmaceuticals. Through its Diagnostics segment, the company provides clinical laboratory and genetic testing services, including BioReference Health and specialized as..
>Volltext.. |
| 1144.6 Mio. EUR |
| 1256 Mio. EUR |
| 452.22 Mio. EUR |
| -53.96 Mio. EUR |
| -133.47 Mio. EUR |
| -0.18 EUR |
| 464.85 Mio. EUR |
| 351.78 Mio. EUR |
| -112.73 Mio. EUR |
| 2.4 |
| -19.07% |
| 15% |
| - |
| - |
| - |
| OPKO HEALTH |
| 13.11.26 |
|
||||
|